---
figid: PMC7464279__cells-09-01817-g007
figlink: pmc/articles/PMC7464279/figure/cells-09-01817-f007/
number: Figure 7
caption: 'Synergistic effect of cyclopamine and rapamycin. C57BL/6N hepatocytes were
  treated with cyclopamine and/or rapamycin for 24 h. The treatment with cyclopamine
  had no effect on mechanistic target of rapamycin (mTOR) signalling, whereas the
  treatment with rapamycin had weak inhibitory effects on p70S6 downstream signalling
  and mitochondrial respiration. However, the simultaneous treatment with cyclopamine
  and rapamycin exhibited strong inhibitory effects on p70S6 downstream signalling
  as well as mitochondrial respiration, revealing an impact of Hh signalling on the
  mTOR pathway. SMO: Smoothened, PTCH: Patched, CK1: Casein kinase 1, FU: Fused, SUFU:
  Suppressor of Fused, GSK3: Glycogen synthase kinase 3, GLI1-3: glioma-associated
  oncogene family zinc finger 1-3, Akt: Protein kinase B, TCS: Tuberous sclerosis
  complex, mTORC1/2; mechanistic target of rapamycin complex 1/2, 4E-BP1: Eukaryotic
  translation initiation factor 4E-binding protein 1, p70S6: Ribosomal protein S6
  kinase beta-1.'
pmcid: PMC7464279
papertitle: Cyclopamine and Rapamycin Synergistically Inhibit mTOR Signalling in Mouse
  Hepatocytes, Revealing an Interaction of Hedgehog and mTor Signalling in the Liver.
reftext: Luise Spormann, et al. Cells. 2020 Aug;9(8):1817.
pmc_ranked_result_index: '18248'
pathway_score: 0.9690597
filename: cells-09-01817-g007.jpg
figtitle: Synergistic effect of cyclopamine and rapamycin
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7464279__cells-09-01817-g007.html
  '@type': Dataset
  description: 'Synergistic effect of cyclopamine and rapamycin. C57BL/6N hepatocytes
    were treated with cyclopamine and/or rapamycin for 24 h. The treatment with cyclopamine
    had no effect on mechanistic target of rapamycin (mTOR) signalling, whereas the
    treatment with rapamycin had weak inhibitory effects on p70S6 downstream signalling
    and mitochondrial respiration. However, the simultaneous treatment with cyclopamine
    and rapamycin exhibited strong inhibitory effects on p70S6 downstream signalling
    as well as mitochondrial respiration, revealing an impact of Hh signalling on
    the mTOR pathway. SMO: Smoothened, PTCH: Patched, CK1: Casein kinase 1, FU: Fused,
    SUFU: Suppressor of Fused, GSK3: Glycogen synthase kinase 3, GLI1-3: glioma-associated
    oncogene family zinc finger 1-3, Akt: Protein kinase B, TCS: Tuberous sclerosis
    complex, mTORC1/2; mechanistic target of rapamycin complex 1/2, 4E-BP1: Eukaryotic
    translation initiation factor 4E-binding protein 1, p70S6: Ribosomal protein S6
    kinase beta-1.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SMO
  - PTCH1
  - CSNK1A1
  - SUFU
  - GSK3A
  - GSK3B
  - AKT2
  - AKT3
  - AKT1
  - GLI1
  - GLI2
  - GLI3
  - TERT
  - EIF4EBP1
  - VGLL3
  - PTCH
  - cyclopamine
  - gapamycin
  - rapamycin
genes:
- word: SMO
  symbol: SMO
  source: hgnc_symbol
  hgnc_symbol: SMO
  entrez: '6608'
- word: PTCH
  symbol: PTCH
  source: hgnc_prev_symbol
  hgnc_symbol: PTCH1
  entrez: '5727'
- word: SMO
  symbol: SMO
  source: hgnc_symbol
  hgnc_symbol: SMO
  entrez: '6608'
- word: PTCH
  symbol: PTCH
  source: hgnc_prev_symbol
  hgnc_symbol: PTCH1
  entrez: '5727'
- word: CK1
  symbol: CK1
  source: hgnc_alias_symbol
  hgnc_symbol: CSNK1A1
  entrez: '1452'
- word: SUFU
  symbol: SUFU
  source: hgnc_symbol
  hgnc_symbol: SUFU
  entrez: '51684'
- word: CK1
  symbol: CK1
  source: hgnc_alias_symbol
  hgnc_symbol: CSNK1A1
  entrez: '1452'
- word: SUFU
  symbol: SUFU
  source: hgnc_symbol
  hgnc_symbol: SUFU
  entrez: '51684'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: GLI1
  symbol: GLI1
  source: hgnc_symbol
  hgnc_symbol: GLI1
  entrez: '2735'
- word: GLI1
  symbol: GLI1
  source: hgnc_symbol
  hgnc_symbol: GLI1
  entrez: '2735'
- word: GLI2
  symbol: GLI2
  source: hgnc_symbol
  hgnc_symbol: GLI2
  entrez: '2736'
- word: GLI3
  symbol: GLI3
  source: hgnc_symbol
  hgnc_symbol: GLI3
  entrez: '2737'
- word: TCS1
  symbol: TCS1
  source: hgnc_alias_symbol
  hgnc_symbol: TERT
  entrez: '7015'
- word: GLI2
  symbol: GLI2
  source: hgnc_symbol
  hgnc_symbol: GLI2
  entrez: '2736'
- word: TCS1
  symbol: TCS1
  source: hgnc_alias_symbol
  hgnc_symbol: TERT
  entrez: '7015'
- word: GLI3
  symbol: GLI3
  source: hgnc_symbol
  hgnc_symbol: GLI3
  entrez: '2737'
- word: GLI1
  symbol: GLI1
  source: hgnc_symbol
  hgnc_symbol: GLI1
  entrez: '2735'
- word: GLI1
  symbol: GLI1
  source: hgnc_symbol
  hgnc_symbol: GLI1
  entrez: '2735'
- word: GLI2
  symbol: GLI2
  source: hgnc_symbol
  hgnc_symbol: GLI2
  entrez: '2736'
- word: GLI2
  symbol: GLI2
  source: hgnc_symbol
  hgnc_symbol: GLI2
  entrez: '2736'
- word: GLI3
  symbol: GLI3
  source: hgnc_symbol
  hgnc_symbol: GLI3
  entrez: '2737'
- word: GLI3
  symbol: GLI3
  source: hgnc_symbol
  hgnc_symbol: GLI3
  entrez: '2737'
- word: 4E-BP1
  symbol: 4E-BP1
  source: hgnc_alias_symbol
  hgnc_symbol: EIF4EBP1
  entrez: '1978'
- word: 4E-BP1
  symbol: 4E-BP1
  source: hgnc_alias_symbol
  hgnc_symbol: EIF4EBP1
  entrez: '1978'
- word: SMO
  symbol: SMO
  source: hgnc_symbol
  hgnc_symbol: SMO
  entrez: '6608'
- word: PTCH
  symbol: PTCH
  source: hgnc_prev_symbol
  hgnc_symbol: PTCH1
  entrez: '5727'
- word: CK1
  symbol: CK1
  source: hgnc_alias_symbol
  hgnc_symbol: CSNK1A1
  entrez: '1452'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: SUFU
  symbol: SUFU
  source: hgnc_symbol
  hgnc_symbol: SUFU
  entrez: '51684'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: GLI1
  symbol: GLI1
  source: hgnc_symbol
  hgnc_symbol: GLI1
  entrez: '2735'
- word: GLI2
  symbol: GLI2
  source: hgnc_symbol
  hgnc_symbol: GLI2
  entrez: '2736'
- word: TCS1
  symbol: TCS1
  source: hgnc_alias_symbol
  hgnc_symbol: TERT
  entrez: '7015'
- word: VGLI3
  symbol: VGLL3
  source: hgnc_symbol
  hgnc_symbol: VGLL3
  entrez: '389136'
- word: GLI3
  symbol: GLI3
  source: hgnc_symbol
  hgnc_symbol: GLI3
  entrez: '2737'
- word: GLI1
  symbol: GLI1
  source: hgnc_symbol
  hgnc_symbol: GLI1
  entrez: '2735'
- word: GLI2
  symbol: GLI2
  source: hgnc_symbol
  hgnc_symbol: GLI2
  entrez: '2736'
- word: GLI3
  symbol: GLI3
  source: hgnc_symbol
  hgnc_symbol: GLI3
  entrez: '2737'
- word: 4E-BP1
  symbol: 4E-BP1
  source: hgnc_alias_symbol
  hgnc_symbol: EIF4EBP1
  entrez: '1978'
chemicals:
- word: PTCH
  source: MESH
  identifier: C498566
- word: cyclopamine
  source: MESH
  identifier: C000541
- word: gapamycin
  source: ''
  identifier: ''
- word: rapamycin
  source: MESH
  identifier: D020123
diseases: []
---
